CD8A and cancer: demonstrated that activated CD8+ T cells were significantly more sensitive to RSL3-induced ferroptosis than cancer cells when CD8+ T cells were co-cultured with cancer cells, resulting in ferroptosis of CD8+ T cells and immune regression against cancer.